Emendo Biotherapeutics Achieves Milestone of Collaboration with Takeda for its OMNI Nuclease Program Read more
Tonix Pharma Expands Preclinical Pipeline with Triple Reuptake Inhibitor, TNX-1600, for the Treatment of PTSD Read more
FDA Accepts New Drug Application for VX-445 (Elexacaftor), Tezacaftor and Ivacaftor Combination Treatment Read more
Vaxxilon Awarded CARB-X Grant to Advance Novel Prophylactic Vaccine to Prevent Klebsiella pneumoniae Infections Read more
Farxiga met primary endpoint in landmark Phase III DAPA-HF trial for the treatment of patients with heart failure Read more
Regulatory and Policy Keynote Sessions to be Delivered at the Wearable Injectors and Connected Devices Conference Read more